Published in Br J Cancer on January 21, 2002
Human kidney injury molecule-1 is a tissue and urinary tumor marker of renal cell carcinoma. J Am Soc Nephrol (2005) 1.71
Phase I study utilizing a novel antigen-presenting cell-targeted vaccine with Toll-like receptor stimulation to induce immunity to self-antigens in cancer patients. Clin Cancer Res (2011) 1.15
Expression of beta-subunit of HCG genes during normal and failed pregnancy. Hum Reprod (2005) 1.03
Human chorionic gonadotropin measurements in parathyroid carcinoma. Eur J Endocrinol (2008) 0.84
Expression of human chorionic gonadotropin beta-subunit type I genes predicts adverse outcome in renal cell carcinoma. J Mol Diagn (2006) 0.79
Clinical significance of serum biomarkers in pediatric solid mediastinal and abdominal tumors. Int J Mol Sci (2012) 0.77
Human chorionic gonadotrophin beta expression in malignant Barrett's oesophagus. Virchows Arch (2004) 0.77
Human Chorionic Gonadotropin and Breast Cancer. Int J Mol Sci (2017) 0.75
Global cancer statistics. CA Cancer J Clin (1999) 8.82
Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol (1982) 8.47
Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma. J Clin Oncol (1999) 8.46
The Heidelberg classification of renal cell tumours. J Pathol (1997) 5.36
Crystal structure of human chorionic gonadotropin. Nature (1994) 3.06
Diagnosis and management of renal cell carcinoma. A clinical and pathologic study of 309 cases. Cancer (1971) 2.56
Renal cell carcinoma: survival and prognostic factors. Urology (1986) 1.75
beta hCG as a prognostic marker in adenocarcinoma of the prostate. J Clin Pathol (1996) 1.55
Vascular endothelial growth factor as prognostic factor in renal cell carcinoma. J Urol (2000) 1.35
The increase in bladder carcinoma cell population induced by the free beta subunit of human chorionic gonadotrophin is a result of an anti-apoptosis effect and not cell proliferation. Br J Cancer (2000) 1.15
Free human chorionic gonadotropin beta subunit in gonadal and nongonadal neoplasms. Cancer Res (1992) 1.13
Elevation of free beta subunit of human choriogonadotropin and core beta fragment of human choriogonadotropin in the serum and urine of patients with malignant pancreatic and biliary disease. Cancer Res (1992) 1.11
Human chorionic gonadotropin detected in urinary concentrates from patients with malignant tumors of the testis, prostate, bladder, ureter and kidney. J Urol (1983) 1.03
Beta human chorionic gonadotrophin in serum and urine. A marker for metastatic urothelial cancer. Br J Urol (1989) 1.00
Interleukin 10 (IL-10): an immunosuppressive factor and independent predictor in patients with metastatic renal cell carcinoma. Br J Cancer (1999) 0.97
Concentrations of human choriogonadotropin, its beta-subunit, and the core fragment of the beta-subunit in serum and urine of men and nonpregnant women. Clin Chem (1992) 0.93
Heterogeneity in renal cell carcinoma and its impact no prognosis--a flow cytometric study. Br J Cancer (1996) 0.88
Evidence for altered synthesis of human chorionic gonadotropin in gestational trophoblastic tumors. J Clin Endocrinol Metab (1976) 0.86
Human chorionic gonadotropin: amino acid sequence of the alpha and beta subunits. Biochem Biophys Res Commun (1972) 0.86
Tumor associated trypsin inhibitor as a prognostic factor in renal cell carcinoma. J Urol (2001) 0.85
Serum concentrations of cancer antigen 125, placental alkaline phosphatase, cancer-associated serum antigen and free beta human chorionic gonadotrophin as prognostic markers for epithelial ovarian cancer. Br J Obstet Gynaecol (1997) 0.84
Evaluation of five glycoprotein tumour markers (CEA, CA-50, CA-19-9, CA-125, CA-15-3) for the prognosis of renal-cell carcinoma. Int J Cancer (1997) 0.83
Choriogonadotropin and its beta subunit separated by hydrophobic-interaction chromatography and quantified in serum during pregnancy by time-resolved immunofluorometric assays. Clin Chem (1988) 0.81
Prognostic significance of cellular proliferation in renal cell carcinoma: a comparison of synthesis-phase fraction and proliferating cell nuclear antigen index. Mod Pathol (1995) 0.78
Human chorionic gonadotropin and free beta subunits stimulate phospholipid methylation in intact rat Leydig cells. Steroids (1993) 0.77
The Heidelberg classification of renal cell tumours. J Pathol (1997) 5.36
Maintaining low HIV seroprevalence in populations of injecting drug users. JAMA (1995) 4.88
A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. Duration of Anticoagulation Trial Study Group. N Engl J Med (1995) 4.71
Insect immunity. Purification and properties of three inducible bactericidal proteins from hemolymph of immunized pupae of Hyalophora cecropia. Eur J Biochem (1980) 4.35
Post-thrombotic syndrome, recurrence, and death 10 years after the first episode of venous thromboembolism treated with warfarin for 6 weeks or 6 months. J Thromb Haemost (2006) 2.32
Follow-up guidelines for nonmetastatic renal cell carcinoma based on the occurrence of metastases after radical nephrectomy. BJU Int (1999) 2.19
Expression of vascular endothelial growth factor protein in human renal cell carcinoma. BJU Int (2004) 1.79
Insect immunity. I. Characteristics of an inducible cell-free antibacterial reaction in hemolymph of Samia cynthia pupae. Infect Immun (1974) 1.78
Serum tumour markers CA 15-3, TPA, TPS, hCGbeta and TATI in the monitoring of chemotherapy response in metastatic breast cancer. Scand J Clin Lab Invest (2001) 1.47
Effect of an in vitro fertilization program on serum CA 125, tumor-associated trypsin inhibitor, free beta-subunit of human chorionic gonadotropin, and common alpha-subunit of glycoprotein hormones. Fertil Steril (2000) 1.40
CEA, CA 19-9 and CA 72-4 improve the diagnostic accuracy in gastrointestinal cancers. Anticancer Res (2002) 1.36
Vascular endothelial growth factor as prognostic factor in renal cell carcinoma. J Urol (2000) 1.35
LRIG1 and epidermal growth factor receptor in renal cell carcinoma: a quantitative RT--PCR and immunohistochemical analysis. Br J Cancer (2003) 1.24
One-month versus six-month therapy with oral anticoagulants after symptomatic deep vein thrombosis. Acta Med Scand (1985) 1.17
Insect immunity. 11. Simultaneous induction of antibacterial activity and selection synthesis of some hemolymph proteins in diapausing pupae of Hyalophora cecropia and Samia cynthia. Infect Immun (1975) 1.13
Subcutaneous administration of heparin. A randomised comparison with intravenous administration of heparin to patients with deep-vein thrombosis. Thromb Res (1982) 1.11
High expression of tumour-associated trypsin inhibitor correlates with liver metastasis and poor prognosis in colorectal cancer. Br J Cancer (2009) 1.11
Telomere shortening in renal cell carcinoma. Cancer Res (1994) 1.07
Erythropoietin in renal cell carcinoma: evaluation of its usefulness as a tumor marker. Eur Urol (1992) 1.04
Fruits and vegetables consumption and the risk of histological subtypes of lung cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC). Cancer Causes Control (2010) 1.02
Treatment of haemophilia A and B and von Willebrand's disease: summary and conclusions of a systematic review as part of a Swedish health-technology assessment. Haemophilia (2011) 1.01
Serum levels of human chorionic gonadotropin in nonpregnant women and men are modulated by gonadotropin-releasing hormone and sex steroids. J Clin Endocrinol Metab (1987) 1.01
Disappearance of human chorionic gonadotropin and its alpha- and beta-subunits after term pregnancy. Clin Chem (1997) 1.01
The role of the fibrinolytic system in deep vein thrombosis. J Lab Clin Med (1985) 1.00
Prognostic importance of serum vascular endothelial growth factor in relation to platelet and leukocyte counts in human renal cell carcinoma. Eur J Cancer Prev (2002) 1.00
Expression of cyclin D1, D3, E, and p27 in human renal cell carcinoma analysed by tissue microarray. Br J Cancer (2003) 1.00
Pharmacokinetics of antimicrobial agents in the elderly. Rev Infect Dis (1987) 0.99
Time-resolved immunofluorometric assays for trypsinogen-1 and 2 in serum reveal preferential elevation of trypsinogen-2 in pancreatitis. J Lab Clin Med (1990) 0.99
Specific genetic changes of diagnostic importance in chromophobe renal cell carcinomas. Lab Invest (1997) 0.98
Pharmacokinetics of ceftazidime in elderly patients and young volunteers. Scand J Infect Dis (1984) 0.97
Noninvasive dual modality in vivo monitoring of the persistence and potency of a tumor targeted conditionally replicating adenovirus. Gene Ther (2005) 0.97
Treatment and overall survival in renal cell carcinoma: a Swedish population-based study (2000-2008). Br J Cancer (2013) 0.96
Interrelationships between plasma testosterone, SHBG, IGF-I, insulin and leptin in prostate cancer cases and controls. Eur J Cancer Prev (2003) 0.95
A high-density tissue microarray from patients with clinically localized prostate cancer reveals ERG and TATI exclusivity in tumor cells. Prostate Cancer Prostatic Dis (2013) 0.95
Preoperative serum concentration of hCGbeta as a prognostic factor in ovarian cancer. Int J Cancer (2001) 0.95
Serum interleukin-6 in relation to acute-phase reactants and survival in patients with renal cell carcinoma. Eur J Cancer (1997) 0.95
Serum acute phase reactants and prognosis in renal cell carcinoma. Cancer (1995) 0.95
DNA content in renal cell carcinoma with reference to tumor heterogeneity. Cancer (1985) 0.94
Tissue expression of human chorionic gonadotropin beta predicts outcome in colorectal cancer: a comparison with serum expression. Int J Cancer (2001) 0.94
Rapid exponential elimination of free prostate-specific antigen contrasts the slow, capacity-limited elimination of PSA complexed to alpha 1-antichymotrypsin from serum. Urology (1998) 0.94
Tumor-associated trypsin inhibitor in normal and malignant renal tissue and in serum of renal-cell carcinoma patients. Int J Cancer (1999) 0.94
Telomerase activity in human renal cell carcinoma. Oncogene (1996) 0.93
Cyclin-D1 expression in human renal-cell carcinoma. Int J Cancer (1999) 0.92
Evaluation of carcinoembryonic antigen, tissue polypeptide antigen, placental alkaline phosphatase, and modified nucleosides as biological markers in malignant lymphomas. Recent Results Cancer Res (1983) 0.91
Developmental changes in 24-hour profiles of luteinizing hormone and follicle-stimulating hormone from prepuberty to midstages of puberty in boys. J Clin Endocrinol Metab (1992) 0.90
Lack of genetic changes at specific genomic sites separates renal oncocytomas from renal cell carcinomas. J Pathol (1998) 0.90
12-O-tetradecanoyl phorbol-13-acetate potentiates adenosine 3',5'-monophosphate-mediated chorionic gonadotropin secretion by cultured human choriocarcinoma cells. Endocrinology (1987) 0.89
Differential expression of trypsinogen and tumor-associated trypsin inhibitor (TATI) in bladder cancer. Int J Oncol (2006) 0.89
Specificity of serum prostate-specific antigen determination in the Finnish prostate cancer screening trial. Br J Cancer (2007) 0.89
Gonadotropins in doping: pharmacological basis and detection of illicit use. Br J Pharmacol (2008) 0.88
False-positive screening results in the Finnish prostate cancer screening trial. Br J Cancer (2010) 0.87
Wilms' tumour 1 can suppress hTERT gene expression and telomerase activity in clear cell renal cell carcinoma via multiple pathways. Br J Cancer (2010) 0.86
Randomised controlled short-term intervention pilot study on rye bran bread in prostate cancer. Eur J Cancer Prev (2003) 0.85
Structural studies, localization in tissue and clinical aspects of human endometrial proteins. J Reprod Fertil Suppl (1988) 0.85
Tumor associated trypsin inhibitor as a prognostic factor in renal cell carcinoma. J Urol (2001) 0.85
Serum beta 2-microglobulin and prognosis of patients with renal cell carcinoma. Acta Oncol (1996) 0.85
Syringe exchange for prevention of HIV infection in Sweden: practical experiences and community reactions. Int J Addict (1991) 0.85
Adherence to the Mediterranean diet and risk of bladder cancer in the EPIC cohort study. Int J Cancer (2013) 0.84
Pharmacokinetics of meropenem in febrile neutropenic patients. Swedish study group. Eur J Clin Microbiol Infect Dis (1997) 0.84
On the source of bile salt-stimulated lipase in human milk: a study based on serum concentrations as determined by sandwich enzyme-linked immunosorbent assay technique. J Pediatr Gastroenterol Nutr (1985) 0.84
High tissue expression of tumour-associated trypsin inhibitor (TATI) associates with a more favourable prognosis in gastric cancer. Histopathology (2005) 0.84
Invasive pneumococcal disease in patients with an underlying pulmonary disorder. Clin Microbiol Infect (2013) 0.84
MMP-9 activation by tumor trypsin-2 enhances in vivo invasion of human tongue carcinoma cells. J Dent Res (2002) 0.84
First trimester hyperglycosylated human chorionic gonadotrophin in serum - a marker of early-onset preeclampsia. Placenta (2013) 0.84
Age dependence of renal function: clearance of iohexol and p-amino hippurate in healthy males. Scand J Clin Lab Invest (1989) 0.84
Vascular endothelial growth factor is bound in amniotic fluid and maternal serum. Hum Reprod (1999) 0.83
Increased oral bioavailability of ciprofloxacin in cystic fibrosis patients. Antimicrob Agents Chemother (1992) 0.83
Evaluation of five glycoprotein tumour markers (CEA, CA-50, CA-19-9, CA-125, CA-15-3) for the prognosis of renal-cell carcinoma. Int J Cancer (1997) 0.83
Oral surgery in patients with hereditary bleeding disorders. A survey of treatment in the Stockholm area (1974-1985). Int J Oral Maxillofac Surg (1989) 0.83
Loss of heterozygosity at chromosome 3p correlates with telomerase activity in renal cell carcinoma. Int J Oncol (1998) 0.82
Neuroendocrine differentiation in renal cell carcinoma--evaluation of chromogranin A and neuron-specific enolase. Acta Oncol (1999) 0.82
Prognostic significance of the DNA content in renal cell carcinoma. J Urol (1986) 0.82
Failure of creatine kinase to predict ectopic pregnancy. Fertil Steril (1996) 0.82
Ovarian hyperstimulation caused by gonadotroph adenoma secreting follicle-stimulating hormone in 28-year-old woman. J Clin Endocrinol Metab (1999) 0.82
Microdialysis for pharmacokinetic studies of ceftazidime in rabbit vitreous. J Ocul Pharmacol Ther (1999) 0.82
Increase in first morning voided urinary luteinizing hormone levels precedes the physical onset of puberty. J Clin Endocrinol Metab (1996) 0.82
Precancerous lesions in the kidney. Scand J Urol Nephrol Suppl (2000) 0.81
Quinolone disposition in the elderly. Practical implications. Drugs Aging (1992) 0.81
Impact of serum basic fibroblast growth factor on prognosis in human renal cell carcinoma. Eur J Cancer (2001) 0.81
Preoperative serum hCGbeta as a prognostic marker in primary fallopian tube carcinoma. Tumour Biol (2005) 0.81
Safety assessment of common foods enriched with natural nonesterified plant sterols. Eur J Clin Nutr (2008) 0.81
Pulsatile secretion of LH and FSH in prepubertal and early pubertal boys revealed by ultrasensitive time-resolved immunofluorometric assays. Pediatr Res (1990) 0.81
Markers supplementing CA 125 in ovarian cancer. Ann Med (1995) 0.81
Comparative studies on neutralisation of primary HIV-1 isolates by human sera and rabbit anti-V3 peptide sera. J Med Virol (1999) 0.81
Chromosomes in renal carcinoma with reference to intratumor heterogeneity. Cancer Genet Cytogenet (1988) 0.81
A comparison of serum and tissue hCG beta as prognostic markers in colorectal cancer. Anticancer Res (2001) 0.81
Re: False-positive prostate specific antigen values in the sera of women with renal cell carcinoma. J Urol (1994) 0.81